Stammdaten
Unternehmen
| Name | GRAIL, Inc. |
|---|---|
| Ticker | GRAL |
| CIK | 0001699031 |
Branche
| SIC-Code | 8071 |
|---|---|
| Beschreibung | Services-Medical Laboratories |
Wertpapier
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | – |
| Titel | GRAIL, Inc. |
Status
| Zuletzt geprüft | 2026-03-20 22:35:54.234036 |
|---|
Fondsaktivität (letzte 3 Quartale)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-03-09 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -7,203 | 47.93 | -345,239.79 | -37,7% | |
| 2026-03-09 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -258 | 46.73 | -12,056.34 | -1,3% | |
| 2026-03-05 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -980 | 53.01 | -51,949.80 | -5,7% | |
| 2026-03-02 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -35,787 | 50.09 | -1,792,402.63 | -195,7% | |
| 2026-03-02 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -1,717 | 51.84 | -89,014.43 | -9,7% | |
| 2025-12-03 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -15,356 | 95.28 | -1,463,092.04 | -159,8% | |
| 2025-12-03 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -14,807 | 94.43 | -1,398,248.70 | -152,7% | |
| 2025-12-03 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -8,233 | 96.22 | -792,152.09 | -86,5% | |
| 2025-12-03 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -1,604 | 97.28 | -156,042.09 | -17,0% | |
| 2025-10-15 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -7,239 | 68.88 | -498,622.32 | -54,4% | |
| 2025-08-19 | Ofman Joshua J. | Officer, President | Open Market Sale | -4,202 | 32.02 | -134,548.04 | -14,7% | |
| 2025-08-19 | Freidin Aaron | Officer, Chief Financial Officer | Open Market Sale | -877 | 32.02 | -28,081.54 | -3,1% | |
| 2025-07-15 | Freidin Aaron | Officer, Chief Financial Officer | Open Market Sale | -8,000 | 38.93 | -311,440.00 | -34,0% | |
| 2025-06-30 | Ofman Joshua J. | Officer, President | Open Market Sale | -9,692 | 52.00 | -503,984.00 | -55,0% | |
| 2025-06-12 | Ofman Joshua J. | Officer, President | Open Market Sale | -9,692 | 42.30 | -410,019.09 | -44,8% | |
| 2025-05-02 | Freidin Aaron | Officer, Chief Financial Officer | Open Market Sale | -41,150 | 33.93 | -1,396,219.50 | -152,5% | |
| 2025-05-02 | Ofman Joshua J. | Officer, President | Open Market Sale | -48,213 | 33.93 | -1,635,867.09 | -178,6% | |
| 2025-05-02 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -94,035 | 33.93 | -3,190,607.55 | -348,4% | |
| 2025-05-02 | RAGUSA ROBERT P | Director, Officer, Chief Executive Officer | Open Market Sale | -94,035 | 33.93 | -3,190,607.55 | -348,4% |
Top-Fondshalter (aktuelles Quartal)
Keine Fondsdaten für das aktuelle Quartal vorhanden.